18.59
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BHVN Giù?
Forum
Previsione
Biohaven Ltd Borsa (BHVN) Ultime notizie
Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March - Yahoo Finance
Corebridge Financial Inc. Acquires 2,552 Shares of Biohaven Ltd. (NYSE:BHVN) - Defense World
KLP Kapitalforvaltning AS Acquires Shares of 16,100 Biohaven Ltd. (NYSE:BHVN) - Defense World
Raymond James Financial Inc. Purchases Shares of 37,033 Biohaven Ltd. (NYSE:BHVN) - Defense World
American Century Companies boosts stake in Biohaven, ETF Daily News says - Yahoo Finance
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven LtdBHVN - PR Newswire
Biohaven Ltd. Shares Tumble Amid Market Reassessment - TipRanks
Biohaven Ltd. (NYSE:BHVN) Shares Bought by American Century Companies Inc. - Defense World
Teacher Retirement System of Texas Raises Stake in Biohaven Ltd. (NYSE:BHVN) - Defense World
(BHVN) Proactive Strategies - Stock Traders Daily
Biohaven stock hits 52-week low at $26.7 amid market challenges By Investing.com - Investing.com South Africa
Biohaven stock hits 52-week low at $26.7 amid market challenges - Investing.com India
Biohaven (BHVN) Stock Price, News & Analysis - MarketBeat
Emerald Advisers LLC Acquires New Holdings in Biohaven Ltd. (NYSE:BHVN) - MarketBeat
Focal Epilepsy Market: Analysis of Epidemiology, Pipeline - openPR
Biohaven Ltd. (NYSE:BHVN) Shares Sold by Amundi - Defense World
Major Player in the Multiple System Atrophy (MSA) Market - openPR
Multiple System Atrophy Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Ionis Pharma, Biohaven Pharma, Lundbeck A/S, Alterity Therapeutics, Theravance Biopharma, Ionis Pharma - Barchart
Multiple System Atrophy Market to Reach New Heights in Growth - openPR
Immunovant data positive for Biohaven, says Deutsche Bank - TipRanks
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biohaven Ltd. (BHVN) and Encourages Shareholders to Learn More About the Investigation - Markets Insider
How To Trade (BHVN) - Stock Traders Daily
Biohaven’s 47% decline validates InvestingPro’s bearish Fair Value call By Investing.com - Investing.com Australia
SEC Form DEF 14A filed by Biohaven Ltd. - Quantisnow
Spinocerebellar Ataxias Pipeline 2025: Therapies, MOA - openPR
Charles Schwab Investment Management Inc. Increases Stock Holdings in Biohaven Ltd. (NYSE:BHVN) - Defense World
Biohaven Ltd. Being Investigated on Behalf of Biohaven Ltd. Investors. Contact Levi & Korsinsky For Details - ACCESS Newswire
US Bancorp DE Raises Stock Position in Biohaven Ltd. (NYSE:BHVN) - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Biohaven Ltd. (BHVN) And Encourages Shareholders to Connect - Markets Insider
Biohaven Ltd. Under Investigation: Levi & Korsinsky Probes Potential Securities Violations - Apna Kal
Investors who lost money on Biohaven Ltd. should contact Levi & Korsinsky about an ongoing investigationBHVN - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Biohaven Ltd. (BHVN) And Encourages Investors to Connect - Markets Insider
Biohaven Ltd. (NYSE:BHVN) Shares Bought by Bank of New York Mellon Corp - Defense World
Unpartnered Obesity Assets Are Becoming Slim Pickings For Pharma - Citeline News & Insights
Bronstein, Gewirtz & Grossman, LLC Encourages Biohaven Ltd. (BHVN) Stockholders to Inquire about Securities Investigation - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biohaven Ltd. (BHVN) and Encourages Investors to Learn More About the Investigation - Markets Insider
Biohaven Ltd. (NYSE:BHVN) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Biohaven Ltd. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Biohaven Ltd. (BHVN) - ACCESS Newswire
Biohaven Ltd. (BHVN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider
ATTENTION Biohaven Ltd. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire
Positive Outlook for Biohaven Ltd. Amid Promising Developments and FDA Priority Review - TipRanks
Independent Director of Biohaven John Childs Buys More Stock - Simply Wall St
Biohaven Ltd. (BHVN): Among Stocks with Heavy Insider Buying in 2025 - Insider Monkey
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biohaven Ltd. (BHVN) and Encourages Stockholders to Learn More About the Investigation - Markets Insider
Biohaven Ltd. Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsBHVN - ACCESS Newswire
Morgan Stanley Lowers Biohaven (NYSE:BHVN) Price Target to $63.00 - Defense World
How to Take Advantage of moves in (BHVN) - Stock Traders Daily
Empowering women in STEM: Navigating CMC regulatory affairs -March 08, 2025 at 04:31 am EST - Marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Encourages Biohaven Ltd. (BHVN) Investors to Inquire about Securities Investigation - markets.businessinsider.com
Biohaven price target lowered to $63 from $69 at Morgan Stanley - Yahoo Finance
Piper Sandler maintains Biohaven stock with $76 target - Investing.com India
Biohaven Ltd. (NYSE:BHVN) Shares Sold by Private Advisor Group LLC - Defense World
JPMorgan Chase & Co. Lowers Biohaven (NYSE:BHVN) Price Target to $68.00 - Defense World
Biohaven FY2025 EPS Forecast Reduced by Cantor Fitzgerald - Defense World
Morgan Stanley cuts Biohaven stock price target to $63 from $69 By Investing.com - Investing.com South Africa
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Biohaven Ltd. (BHVN) And Encourages Investors to Reach Out - Markets Insider
Morgan Stanley cuts Biohaven stock price target to $63 from $69 - Investing.com India
Optimistic Buy Rating for Biohaven Ltd. Amid Promising Drug Developments and Strategic Pipeline Advancements - TipRanks
Royal Bank of Canada Reaffirms “Outperform” Rating for Biohaven (NYSE:BHVN) - Defense World
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):